Wien, Austria

Bernhard Kuenburg


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Vienna, AT (2000 - 2003)
  • Wien, AT (2006)

Company Filing History:


Years Active: 2000-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Bernhard Kuenburg: Pioneering Benzazepine Derivatives

Introduction

Bernhard Kuenburg, located in Wien, Austria, is a remarkable inventor known for his contributions to medicinal chemistry, specifically in the development of benzazepine derivatives. With a total of three patents to his name, Kuenburg has significantly impacted the field of pharmaceuticals, particularly concerning treatments for neurodegenerative diseases.

Latest Patents

Kuenburg's latest patents focus on the innovative use of benzazepine derivatives and their applications in drug formulation. His work encompasses new derivatives of benzazepine, especially the benzofuro[3a,3,2,ef][2]benzazepin of the general formula (I). Kuenburg's discoveries highlight compounds of the general formula (III) that are integral in creating drugs designed for the treatment of Alzheimer's disease, related dementia conditions, and Langdon-Down syndrome. These advancements represent a significant leap forward in therapeutic options available for patients suffering from these challenging conditions.

Career Highlights

Throughout his career, Bernhard Kuenburg has collaborated with significant companies in the pharmaceutical sector, including Sanochemia Ltd. and Sanochemia Pharmazeutica Aktiengesellschaft. His work in these organizations has enabled him to push the boundaries of traditional medicine and develop innovative solutions that address critical health issues.

Collaborations

Kuenburg has worked alongside esteemed colleagues such as Laszlo Czollner and Johannes Frohlich. Together, they have made meaningful contributions to the understanding and application of benzazepine derivatives in medicinal chemistry, showcasing the value of collaboration in scientific research.

Conclusion

Bernhard Kuenburg's contributions to the field of inventions, particularly in the development of benzazepine derivatives, demonstrate his dedication to enhancing medical treatments. His innovative patents not only showcase his expertise but also reflect the potential for novel therapeutic approaches in the fight against neurodegenerative diseases. The work of Kuenburg and his collaborators continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…